medigraphic.com

2023, Number 4

Next >>

Rev Hematol Mex 2023; 24 (4)

Hematological parameters in patients attending a retina consultation

Pérez CHJ, Márquez MAM, Pérez RI, Morales LO, Somilleda VSA

Language: Spanish
References: 31
Page: 179-187
PDF size: 245.01 Kb.


ABSTRACT

Objective: To describe the erythrocyte findings in patients who attend a retina consultation for the first time.
Materials and Methods: A retrospective, cross-sectional and descriptive study was done in which records of patients who attended the retina consultation for the first time from 2014 to 2018 were reviewed. The results of the erythrocyte series were obtained and a descriptive statistical analysis was performed with measures of central tendency. GraphPad Prism V5.0 software was used for comparative tests.
Results: Nine hundred sixty-four files with complete blood count results were analyzed. The average age was 64.6 and 59.8 years for women and men, respectively. The average erythrocyte values for women were: erythrocytes 4.48 M/µL, hemoglobin 13.74 g/dL, hematocrit 40.14%, mean corpuscular volume (MCV) 89.2 fL, mean corpuscular hemoglobin (MCH) 30.82 pg and mean corpuscular hemoglobin concentration (MCHC) 34.56 g/dL, while for men they were: erythrocytes 4.62 M/μL, hemoglobin 14.56 g/dL, hematocrit 41.78%, MCV 90.2 fL, MCH 31.22 pg and MCHC 34.86 g/dL.
Conclusions: It is suggested that in the population with hemoconcentration or anemia there is a relationship with systemic diseases such as diabetes, hypertension, obesity or dyslipidemia. This study is relevant because, in the future, the results found will serve to carry out a more detailed analysis and find out the types of systemic diseases that patients present.


REFERENCES

  1. Jansen V. Diagnosis of anemia-A synoptic overview andpractical approach. Transfus Apher Sci 2019; 58 (4): 375-385. doi: 10.1016/j.transci.2019.06.012.

  2. Organización Mundial de la Salud (OMS). Concentracionesde hemoglobina para diagnosticar la anemia y evaluarsu gravedad. Ginebra, Organización Mundial de la Salud,2011 (WHO/NMH/NHD/MNM/11.1) http://www.who.int/vmnis/indicators/haemoglobin_es.pdf.

  3. Mateos González ME, de la Cruz Bértolo J, López Laso E,Valdés Sánchez MD, Nogales Espert A. Revisión de losparámetros hematológicos y bioquímicos para identificarla ferropenia. An Pediatr (Barc) 2009; 71 (2): 95-102. doi:10.1016/j.anpedi.2009.04.004.

  4. Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology,and etiology in low- and middle-incomecountries. Ann N Y Acad Sci 2019; 1450 (1): 15-31. doi:10.1111/nyas.14092.

  5. Secomb TW. Mechanics of blood flow in the microcirculation.Symp Soc Exp Biol 1995; 49: 305-21.

  6. Saqr KM, Tupin S, Rashad S, Endo T, Niizuma K, Tominaga T,Ohta M. Physiologic blood flow is turbulent. Sci Rep 2020;10 (1): 15492. doi: 10.1038/s41598-020-72309-8.

  7. Wiciński M, Liczner G, Cadelski K, Kołnierzak T, NowaczewskaM, Malinowski B. Anemia of chronic diseases: Widerdiagnostics-better treatment? Nutrients 2020; 12 (6): 1784.doi: 10.3390/nu12061784.

  8. Madu AJ, Ughasoro MD. Anaemia of chronic disease: Anin-depth review. Med Princ Pract 2017; 26 (1): 1-9. doi:10.1159/000452104.

  9. Weiss G, Ganz T, Goodnough LT. Anemia of inflammation.Blood 2019; 133 (1): 40-50. doi: 10.1182/blood-2018-06-856500.

  10. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, MurrayCJ; Comparative Risk Assessment Collaborating Group.Selected major risk factors and global and regional burdenof disease. Lancet 2002; 360 (9343): 1347-60. doi: 10.1016/S0140-6736(02)11403-6.

  11. Rodríguez GM, Borregero-León JM, González RE, Viña-RodríguezJJ, Serrano GM, Santolaria FF. Factores de riesgo vasculary enfermedad obstructiva microvascular de la retina [Vascularrisk factors and retinal occlusive disease]. Med Clin (Barc)2010; 134 (3): 95-100. doi: 10.1016/j.medcli.2009.05.043.

  12. Medina CA, Townsend JH, Singh AD. Manual of retinaldisease. Springer, 2016.

  13. Sharma Y, Saxena S, Mishra A, Saxena A, Natu SM. Nutritionfor diabetic retinopathy: plummeting the inevitable threatof diabetic vision loss. Eur J Nutr 2017; 56 (6): 2013-2027.doi: 10.1007/s00394-017-1406-2.

  14. Loewenstein JI. Retinopathy associated with blood anomalies.In: Jakobieck F, editor. Clinical Ophthalmology. Philadelphia:JB Lippincott Company, 1995; 3 (85): 995-1000.

  15. López-Santiago N. La biometría hemática. Acta Pediatr Mex2016; 37 (4): 246-249.

  16. Torrens PM. Interpretación clínica del hemograma. RevMed Clin CONDES 2015; 26 (6): 713-725.

  17. McLean E, Cogswell M, Egli I, Wojdyla D, de BenoistB. Worldwide prevalence of anaemia, WHO Vitaminand Mineral Nutrition Information System, 1993-2005.Public Health Nutr 2009; 12 (4): 444-54. doi: 10.1017/S1368980008002401.

  18. Barbui T, Thiele J, Gisslinger H, Finazzi G, Carobbio A, RumiE, et al. Masked polycythemia vera (mPV): results of aninternational study. Am J Hematol 2014; 89 (1): 52-4. doi:10.1002/ajh.23585.

  19. Sasiain MR. Enfermedades de la sangre y ojo. Rev Clin Esp1951; 42: 242-8.

  20. Lang GE, Lang SJ. Ocular findings in hematological diseases.Ophthalmologe 2011; 108 (10): 981-93. doi: 10.1007/s00347-011-2430-x.

  21. Huerta-Aragonés J, Cela de Julián E. Hematología práctica:interpretación del hemograma y de las pruebas de coagulación.En: AEPap (ed.). Curso de Actualización Pediatría2018. Madrid: Lúa Ediciones 3.0; 2018: 507-526.

  22. Terry-Leonard NR, Mendoza-Hernández CA, Meneses-Rodríguez Y. Evaluación el síndrome anémico en el adultomayor. Medisur 2019; 17 (4): 525-539.

  23. Le CH. The prevalence of anemia and moderate-severeanemia in the US population (NHANES 2003-2012). PLoSOne 2016; 11 (11): e0166635. doi: 10.1371/journal.pone.0166635.

  24. Silva-Vera M, Jiménez-González MJ, Moreno-Pérez NE,Moreno-Pizarro E, Máximo-Galicia P. Policitemia vera yneutropenia severa. Hematol Méx 2020; 21 (3): 153-157.doi:10.24245/rev_hematol.v21i3.3874.

  25. Díaz-Lazo A. Sobrepeso y síndrome metabólico en adultosde altura. Rev Per Card 2006; 23 (3): 173-193.

  26. Cohen E, Kramer M, Shochat T, Goldberg E, Krause I.Relationship between hematocrit levels and intraocularpressure in men and women: A population-based crosssectionalstudy. Medicine (Baltimore) 2017; 96 (41): e8290.doi: 10.1097/MD.0000000000008290.

  27. Luo W, Hu L, Wang F. The protective effect of erythropoietinon the retina. Ophthalmic Res 2015; 53 (2): 74-81. doi:10.1159/000369885.

  28. Brun JF, Varlet-Marie E, Fédou C, Raynaud de MauvergerE. Optimal vs actual hematocrit in obesity and overweight.Clin Hemorheol Microcirc 2016; 64 (4): 593-601. doi:10.3233/CH-168013.

  29. Emamian M, Hasanian SM, Tayefi M, Bijari M, MovahedianFar F, Shafiee M, et al. Association of hematocrit with bloodpressure and hypertension. J Clin Lab Anal 2017; 31 (6):e22124. doi: 10.1002/jcla.22124.

  30. Álvarez-Sala W. Poliglobulias secundarias hipóxicas. ArchBronconeumol 1989; 25 (7): 282-294. doi:10.1016/S0300-2896(15)31693-8.

  31. Tamariz LJ, Young JH, Pankow JS, Yeh HC, Schmidt MI, AstorB, Brancati FL. Blood viscosity and hematocrit as risk factorsfor type 2 diabetes mellitus: the atherosclerosis risk incommunities (ARIC) study. Am J Epidemiol 2008; 168 (10):1153-60. doi: 10.1093/aje/kwn243.




2020     |     www.medigraphic.com